Research review
Does dandelion root help the liver? What the research does and doesn't show
No human trial has tested dandelion root against fatty liver or any liver disease. Animal studies found dandelion root or leaf extract reduced liver-injury markers and liver fat in rats and mice with damaged or fatty livers — real findings, but from lab animals, not people. A separate section covers what the (also animal-only) kidney-stone research shows.
No human trial has tested dandelion root against liver disease or fatty liver. What exists is animal research: rat and mouse studies where a dandelion root or leaf extract reduced liver-injury markers, liver fat, or liver inflammation after the animals' livers were damaged or fatty by design — real findings, but from lab animals, not people.
What the evidence doesn't support
It doesn't support dandelion root tea, capsules or extract as a treatment for fatty liver (NAFLD/MASLD), hepatitis, cirrhosis or any diagnosed liver disease. No trial has given a person with liver disease dandelion root and measured their liver function tests, imaging or biopsy results before and after. The animal research below is real and specific, but it stops at the species line — none of it has been repeated in a human trial.
What the trials found
One rat study induced acute-on-chronic liver failure, then pretreated the animals with an ethanolic dandelion root extract (at 50, 100 or 200 mg/kg/day) or with silymarin (a milk thistle extract used as a comparator arm in the same experiment) before the injury. Rats given the dandelion extract showed reduced liver-injury blood markers (AST, ALT, ALP, GGT, bilirubin), reduced kidney markers, and reduced oxidative-stress markers compared with untreated injured rats, along with less liver tissue damage on histology. The published abstract doesn't report how the dandelion and silymarin arms compared to each other — only that both were tested.
A separate mouse study fed animals a high-fat diet, with one group's diet also supplemented with dandelion leaf extract (2 or 5 g/kg of feed). The supplemented mice had less liver fat accumulation and lower liver weight than mice on the high-fat diet alone, along with reduced blood triglycerides, cholesterol, insulin and fasting glucose.
A 2026 mouse study went further into fatty liver disease specifically (MASLD, the current clinical term for what used to be called NAFLD), testing taraxasterol — one purified compound found in dandelion, not the whole root or leaf — on a high-fat-diet model. The compound reduced hepatic fat accumulation and inflammation by activating a liver receptor pathway (FXR); researchers describe it as a "promising candidate" worth further study, not an established treatment, and it's an isolated compound tested in mice, not dandelion root as sold.
Across this research, the pattern is consistent: dandelion root or leaf extract, and one of its purified compounds, show favorable effects on liver-injury and liver-fat markers in animals whose livers were experimentally damaged or fattened. None of it has been tested in a person, and none of the doses used translate directly into a cup of tea or a capsule count.
What about dandelion root and the kidneys?
The liver and kidneys are different organs, and the research on each is separate. Several searches for dandelion root and "kidney disease" or "kidney stones" are really asking about the kidneys specifically, not the liver — here's what that research shows on its own.
On kidney stones: an in-vitro study mixed taraxasterol and a dandelion extract into synthetic urine and found both slowed the formation of calcium oxalate crystals, alongside potassium citrate (a standard preventive treatment) tested for comparison in the same experiment — a test-tube finding, not a human or even animal one. A separate rat study induced kidney stones with ethylene glycol, then gave the animals taraxasterol; treated rats had fewer and smaller crystal deposits and less kidney tissue damage than untreated stone-forming rats, with potassium citrate again included as its own comparator arm. An older rat study (1994) tested dandelion among seven traditional plants for urolithiasis and found modest effects on urine chemistry, concluding that "more effective and equally innocuous substances are well known" — a dated study, but an honest one about dandelion's limits here. No human trial has tested dandelion root against kidney stones.
On chronic kidney disease: no human trial has tested dandelion root here either. If you have diagnosed kidney disease, dandelion's diuretic effect and unstudied effect on potassium and fluid balance are reasons to talk to your doctor before using it, not reasons to expect a benefit — see who should not take dandelion root.
Questions people ask
How does dandelion root help the liver?
No human trial has shown that it does. In animal studies, dandelion root or leaf extract reduced liver-injury markers and liver fat after the animals' livers were experimentally damaged or fed a high-fat diet — but this hasn't been tested in a person, so there's no confirmed mechanism or effect at a human dose.
Is dandelion root good for fatty liver?
No human trial has tested this. The closest evidence is a mouse study (dandelion leaf extract reduced liver fat and liver weight on a high-fat diet) and a mouse study of a purified dandelion compound (taraxasterol) on a fatty-liver-disease model — both animal findings.
How much dandelion root should I take for fatty liver?
There's no dose to recommend, because no human trial has tested any dose of dandelion root against fatty liver. See dandelion root dosage for what's actually on labels and why it isn't trial-derived for this use.
Is dandelion root bad for your liver?
No study or case report has found this. The available research (allergy findings, drug-interaction reviews, and the animal liver studies above) doesn't report liver harm from dandelion root — but anyone with existing liver disease should still ask a doctor before adding any supplement.
When to talk to a doctor
Dandelion root is not a treatment for fatty liver, hepatitis, cirrhosis, kidney stones or chronic kidney disease, and nothing in the animal research above supports using it instead of a doctor's diagnosis, monitoring or treatment for any of these. If you have a liver or kidney condition, or take a medication processed by either organ, check with your doctor or pharmacist before adding dandelion root. See who should not take dandelion root and dandelion root and medications.
Sources
- Protective Effects of Taraxacum officinale L. (Dandelion) Root Extract in Experimental Acute on Chronic Liver Failure In rats with an induced liver injury, a dandelion root extract given beforehand reduced liver-enzyme and oxidative-stress markers compared with untreated rats — an animal study in a disease model, not evidence for people.
- Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver In mice fed a high-fat diet, adding dandelion leaf extract to the feed resulted in less weight gain, less liver fat, and better blood sugar and cholesterol markers than the high-fat diet alone — an animal study of leaf extract, not root, and not a human weight-loss trial.
- Taraxasterol from dandelion improves glycolipid metabolism dysfunction in diet-induced metabolic dysfunction-associated steatotic liver disease by modulating hepatic FXR In mice fed a high-fat diet, a purified dandelion compound (taraxasterol) reduced liver fat buildup and inflammation markers by acting on a specific liver receptor — an animal study of an isolated compound, not whole dandelion root, and described by its own authors as a candidate for further research, not an established treatment.
- Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: in vitro study In a test-tube model of synthetic urine, a dandelion extract and one of its compounds (taraxasterol) slowed the formation of calcium-oxalate crystals, the type that forms most kidney stones — a test-tube finding, not a human or animal one, with potassium citrate (a standard preventive treatment) tested for comparison in the same experiment.
- Antiurolithiatic effect of the taraxasterol on ethylene glycol induced kidney calculi in male rats In rats with chemically induced kidney stones, a purified dandelion compound (taraxasterol) reduced crystal deposits and kidney tissue damage compared with untreated rats, with potassium citrate (a standard stone-prevention treatment) tested as its own separate arm in the same study — an animal study, not a human one.
- Urolithiasis and phytotherapy An older (1994) rat study tested dandelion among several traditional plants for kidney-stone-related urine changes and found modest effects, with the study's own authors concluding better options already existed — a dated, modest finding, not a human trial.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.